Table 2 Treatment-related toxicity
| Â | GNRI/sarcopenia risk | P | |
|---|---|---|---|
High cachexia risk (n = 71) | Low cachexia risk (n = 157) | ||
Hematologic toxicity, grade ≥ 3 | |||
 Anemia | 22 (31.0) | 23 (14.7) | 0.004 |
 Neutropenia | 60 (84.5) | 127 (80.9) | 0.510 |
 Febrile neutropenia | 31 (43.7) | 41 (26.1) | 0.008 |
 Thrombocytopenia | 31 (43.7) | 29 (18.5) | <  0.001 |
Any non-hematologic toxicity, grade ≥ 3 | 35 (49.3) | 48 (30.6) | 0.007 |
Treatment-related mortality | 14 (19.7) | 6 (3.8) | <  0.001 |
Early treatment discontinuation | 28 (39.4) | 12 (7.6) | <  0.001 |